Turning Point Therapeutics, Inc. (NASDAQ:TPTX)

About the company

Turning Point Therapeutics, Inc. engages in the discovery and development of precision medicines for cancer and other diseases. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by J. Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

95

$NoneM

Total Revenue

95

Employees

$2B

Market Capitalization

-19.33

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 375797.27 82729.00 6.04 21.90 20.75
Merck & Co., Inc. MRK 200455.93 48081.00 7.53 19.78 21.10
Pfizer Inc. PFE 190327.35 50660.00 2.88 12.05 31.17
Eli Lilly & Co. LLY 149909.40 23087.00 50.87 26.42 23.97
AbbVie, Inc. ABBV 147123.76 34057.00 -23.55 17.55 24.65
Bristol Myers Squibb Co. BMY 110955.81 31006.00 2.69 94.33 3.08
Repligen Corp. RGEN 6333.69 286.00 6.07 275.98 8.11
Reata Pharmaceuticals, Inc. RETA 4836.62 20.00 22.91 -15.56 -150.30
Nektar Therapeutics NKTR 4127.20 137.00 3.22 -8.98 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3604.64 1.00 33.33 -5.51 None
Allakos, Inc. ALLK 3339.11 None 7.25 -35.70 None
Karuna Therapeutics, Inc. KRTX 2767.96 None 7.23 -68.24 None
ADC Therapeutics SA ADCT 2527.74 2.00 29.82 -21.67 None
Turning Point Therapeutics, Inc. TPTX 2310.84 None 6.95 -19.33 None
IGM Biosciences, Inc. IGMS 2230.14 None 9.83 -41.11 None
Apellis Pharmaceuticals, Inc. APLS 2155.56 None 9.52 -5.17 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
OPKO Health, Inc. OPK 2088.87 891.00 1.48 -7.15 -32.92
Springworks Therapeutics, Inc. SWTX 1779.34 None 5.78 -28.54 None
Principia Biopharma, Inc. PRNB 1575.84 30.00 5.61 -22.42 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1556.96 None 9.54 -16.90 None
Zymeworks, Inc. ZYME 1514.94 26.00 3.14 -8.93 -629.37
Kiniksa Pharmaceuticals Ltd. KNSA 1401.40 None 7.26 -11.58 None
Akcea Therapeutics, Inc. AKCA 1348.30 341.00 2.77 -47.93 -8.59
Tricida, Inc. TCDA 1312.71 None 6.75 -6.22 None
Odonate Therapeutics, Inc. ODT 1233.37 None 10.10 -10.96 None
Arcutis Biotherapeutics, Inc. ARQT 1221.37 None 5.21 -19.53 None
Athenex, Inc. ATNX 1073.28 123.00 6.58 -9.97 -87.86
Phibro Animal Health Corp. PAHC 1050.83 818.00 5.31 28.48 4.49
Akero Therapeutics, Inc. AKRO 967.73 None 8.08 -19.07 None
Oric Pharmaceuticals, Inc. ORIC 957.32 None -10.39 -31.66 None
Constellation Pharmaceuticals, Inc. CNST 906.56 None 3.77 -9.77 None
G1 Therapeutics, Inc. GTHX 902.50 1.00 3.91 -6.88 None
Phathom Pharmaceuticals, Inc. PHAT 822.75 None 4.56 -3.02 None
Aprea Therapeutics, Inc. APRE 816.06 None 7.22 -24.14 None
Applied Therapeutics, Inc. APLT 795.30 None 5.13 -16.14 None
Gossamer Bio, Inc. GOSS 793.00 None 3.22 -3.99 None
Krystal Biotech, Inc. KRYS 773.16 None 4.51 -37.28 None
Quanterix Corp. QTRX 750.60 60.00 6.62 -17.16 -71.52
Keros Therapeutics, Inc. KROS 675.18 8.00 -30.50 -31.79 -285.35
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Amneal Pharmaceuticals, Inc. AMRX 635.68 1679.00 4.38 -2.92 -11.85
Arcturus Therapeutics Holdings, Inc. ARCT 610.74 19.00 56.60 -21.95 -151.34
Oyster Point Pharma, Inc. OYST 606.48 None 6.09 -10.54 None
SIGA Technologies, Inc. SIGA 503.48 19.00 5.63 -25.58 -94.00
Mirum Pharmaceuticals, Inc. MIRM 497.00 None 3.23 -7.34 None
Satsuma Pharmaceuticals, Inc. STSA 488.92 None 4.81 -13.44 None
Imara, Inc. IMRA 469.71 None 4.54 -13.35 None
DURECT Corp. DRRX 465.00 28.00 35.71 -19.23 -82.94
Biospecifics Technologies Corp. BSTC 443.10 40.00 3.60 18.95 61.80
Crinetics Pharmaceuticals, Inc. CRNX 423.84 1.00 5.35 -7.27 -447.78
Relmada Therapeutics, Inc. RLMD 402.75 0.00 6.01 -33.65 -877.66
Ocular Therapeutix, Inc. OCUL 396.48 6.00 -48.59 -4.32 None
Fulcrum Therapeutics, Inc. FULC 392.61 1.00 6.62 -5.69 None
Kala Pharmaceuticals, Inc. KALA 383.40 6.00 4.19 -4.18 None
TCR2 Therapeutics, Inc. TCRR 374.16 None 2.56 -37.12 None
Osmotica Pharmaceuticals Plc OSMT 363.42 232.00 2.76 -1.32 -115.44
Ovid Therapeutics, Inc. OVID 328.95 None 7.78 -5.04 None
Urovant Sciences Ltd. UROV 315.00 None -5.59 -2.18 None
Aeglea Biotherapeutics, Inc. AGLE 307.89 4.00 9.72 -3.84 -523.27
HOOKIPA Pharma, Inc. HOOK 302.12 13.00 2.73 -6.68 -333.02
89bio, Inc. ETNB 297.09 None 3.67 -4.60 None
IDEAYA Biosciences, Inc. IDYA 284.20 None 4.32 -6.52 None
AMAG Pharmaceuticals, Inc. AMAG 280.33 321.00 1.07 -0.76 -115.05
Lannett Co., Inc. LCI 268.66 542.00 0.92 -8.84 -5.77
Verrica Pharmaceuticals, Inc. VRCA 254.00 None 4.64 -8.33 None
Spero Therapeutics, Inc. SPRO 251.75 12.00 3.31 -3.10 -656.72
Gritstone Oncology, Inc. GRTS 235.80 4.00 2.11 -2.26 None
Kaleido Biosciences, Inc. KLDO 228.00 None 8.09 -3.11 None
KalVista Pharmaceuticals, Inc. KALV 218.16 12.00 2.41 -6.73 -263.38
Veru, Inc. VERU 218.08 39.00 7.29 -22.37 -25.53
LogicBio Therapeutics, Inc. LOGC 201.71 1.00 6.09 -4.74 None
Liquidia Technologies, Inc. LQDA 182.16 8.00 10.75 -3.70 -602.17
Galera Therapeutics, Inc. GRTX 180.50 None 3.37 -2.75 None
Sutro Biopharma, Inc. STRO 174.22 41.00 3.31 -2.86 -148.06
Protara Therapeutics, Inc. TARA 169.20 None 2.55 -10.97 None
Avenue Therapeutics, Inc. ATXI 168.00 532.00 30.88 -11.54 26.69
Evelo Biosciences, Inc. EVLO 165.12 None 4.23 -1.88 None
Evolus, Inc. EOLS 162.00 45.00 2.90 -1.60 -217.51
Cyclerion Therapeutics, Inc. CYCN 156.60 6.00 1.97 -1.51 None
Tyme Technologies, Inc. TYME 152.95 None 8.87 -7.00 None
scPharmaceuticals, Inc. SCPH 140.50 119.00 3.59 -4.48 -27.05
Aquestive Therapeutics, Inc. AQST 136.08 49.00 -7.84 -1.94 -139.64
Lyra Therapeutics, Inc. LYRA 135.12 1.00 -1.15 -8.10 -491.16
Harrow Health, Inc. HROW 134.68 51.00 8.63 -5.45 -47.54
PhaseBio Pharmaceuticals, Inc. PHAS 133.40 2.00 2.47 -2.79 None
Trevi Therapeutics, Inc. TRVI 125.82 None 2.67 -4.29 None
Mustang Bio, Inc. MBIO 125.80 None 2.94 -2.56 None
NeuBase Therapeutics, Inc. NBSE 122.92 None 51.65 -2.75 None
Ayala Pharmaceuticals, Inc. AYLA 120.00 3.00 -2.82 -5.81 -679.19
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
TFF Pharmaceuticals, Inc. TFFP 109.44 None 4.24 -2.82 None
Eton Pharmaceuticals, Inc. ETON 103.14 1.00 11.24 -5.16 None
Milestone Pharmaceuticals, Inc. MIST 94.25 None 0.93 -1.51 None
EyePoint Pharmaceuticals, Inc. EYPT 82.84 26.00 5.85 -1.69 -196.30
Clearside Biomedical, Inc. CLSD 82.00 6.00 10.53 -4.65 -293.61
Corvus Pharmaceuticals, Inc. CRVS 78.01 None 1.25 -1.65 None
Checkpoint Therapeutics, Inc. CKPT 76.80 2.00 6.62 -3.31 -949.53
Xeris Pharmaceuticals, Inc. XERS 76.44 4.00 3.79 -0.59 None
Baudax Bio, Inc. BXRX 74.70 None -2.03 -1.06 None
Navidea Biopharmaceuticals, Inc. NAVB 69.19 1.00 -50.88 -6.26 -65.13
Genprex, Inc. GNPX 59.66 None 5.06 -4.36 None
BiomX, Inc. PHGE 59.51 None 1.57 -1.39 None
Assertio Therapeutics, Inc. ASRT 59.40 192.00 1.03 -0.36 -83.99
Aridis Pharmaceuticals, Inc. ARDS 59.31 1.00 -24.41 -2.03 -851.00
Menlo Therapeutics, Inc. MNLO 52.49 2.00 4.41 -0.56 -483.51
Aerpio Pharmaceuticals, Inc. ARPO 52.48 20.00 1.58 -2.78 -51.58
Eyenovia, Inc. EYEN 45.44 None 4.58 -2.22 None
Moleculin Biotech, Inc. MBRX 44.35 None 3.86 -4.82 None
Edesa Biotech, Inc. EDSA 44.19 0.00 6.29 -0.46 -395.23
Allena Pharmaceuticals, Inc. ALNA 36.34 None 4.79 -0.84 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Oncternal Therapeutics, Inc. ONCT 35.10 3.00 4.50 -1.39 -225.89
CNS Pharmaceuticals, Inc. CNSP 33.44 None 5.81 -6.15 None
AgeX Therapeutics, Inc. AGE 32.90 2.00 -43.29 -2.71 -658.11
Acer Therapeutics, Inc. ACER 32.00 3.00 2.34 -1.23 -274.69
Aileron Therapeutics, Inc. ALRN 31.64 None 4.35 -1.19 None
Adamis Pharmaceuticals Corp. ADMP 31.32 22.00 1.20 -1.06 -140.33
Annovis Bio, Inc. ANVS 30.52 None 2.79 -24.22 None
Mannatech, Inc. MTEX 30.32 156.00 1.28 6.83 3.45
Citius Pharmaceuticals, Inc. CTXR 29.70 None 2.20 -1.72 None
Millendo Therapeutics, Inc. MLND 27.15 0.00 0.64 -0.58 None
Hoth Therapeutics, Inc. HOTH 25.30 None 7.03 -2.81 None
Spring Bank Pharmaceuticals, Inc. SBPH 23.52 0.00 0.89 -0.90 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.79 1.00 8.24 -1.12 None
ProPhase Labs, Inc. PRPH 16.92 9.00 1.53 -5.64 -31.15
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Adial Pharmaceuticals, Inc. ADIL 14.20 None 3.46 -1.87 None
PDS Biotechnology Corp. PDSB 14.07 None 1.56 -0.55 None
Novan, Inc. NOVN 14.01 5.00 -3.22 -0.44 -602.34
Titan Pharmaceuticals, Inc. TTNP 11.80 4.00 4.92 -0.66 -437.91
Novus Therapeutics, Inc. NVUS 7.30 None 0.62 -0.35 None
Brickell Biotech, Inc. BBI 5.00 5.00 1.64 -0.07 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Is Turning Point Brands, Inc. (TPB) A Good Stock To Buy?

3d ago, source: YAHOO!

We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC ...

Turning Point Therapeutics' Lead Drug Candidate Repotrectinib Increases Effectiveness of KRAS-G12C and MEK Inhibitors in Preclincal KRAS Cancer Models

9d ago, source: Benzinga.com

Turning Point Therapeutics, Inc. (NASDAQ:TPTX), a precision oncology company developing next-generation therapies that ...

Turning Point Therapeutics’ (TPTX) “Buy” Rating Reaffirmed at HC Wainwright

8d ago, source: modernreaders.com

HC Wainwright reissued their buy rating on shares of Turning Point Therapeutics (NASDAQ:TPTX) in a research report released ...

Turning Point Therapeutics Inc

8d ago, source: Bloomberg

Turning Point Therapeutics, Inc. operates as a biopharmaceutical company. The Company designs and develops novel small molecule to treat cancer related diseases. Turning Point Therapeutics serves ...

Turning Point Therapeutics (NASDAQ:TPTX) Shares Purchased by JPMorgan Chase & Co.

7d ago, source: theenterpriseleader.com

JPMorgan Chase & Co. lifted its position in Turning Point Therapeutics (NASDAQ:TPTX) by 56.2% in the first quarter, according to the company in its most recent 13F filing with the Securities & ...

Turning Point Therapeutics (NASDAQ:TPTX) Short Interest Down 16.2% in June

11d ago, source: modernreaders.com

Turning Point Therapeutics (NASDAQ:TPTX) was the target of a large decrease in short interest during the month of June. As of June 15th, there was short interest totalling 2,740,000 shares, a decrease ...

Turning Point Therapeutics Inc Registered Shs Overweight

1mon ago, source: Business Insider

Analyst Opinions for Turning Point Therapeutics Inc Registered ShsMore Latest Analyst Opinions 02:41 AM 06/08/2020 02:41:56 AM UTC-0400 Molson Coors Brewing Company (MCBC Equal Weight Morgan ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.